AstraZeneca

Second COVID-19 trial paused within 24 hours over safety concerns

The Covid-19 treatment studied in the paused trial was based on an effective antibody Lilly found in a recovered patient.

published on : 14th October 2020

Oxford and AstraZeneca resume coronavirus vaccine trial

In a statement, the university confirmed the restart across all of its U.K. clinical trial sites after regulators gave the go-ahead following the pause on Sunday.

published on : 12th September 2020

Oxford vaccine trial stopped after volunteer developed neurological symptoms: AstraZeneca

The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.

published on : 11th September 2020

'Reviewing situation': Serum Institute pauses COVID-19 vaccine trials in India after DCGI notice

The drug regulator's move comes after AstraZeneca, which is developing the vaccine candidate against COVID-19 with researchers of Oxford University

published on : 10th September 2020

Mysuru: Oxford vaccine trials halted in UK, but JSS institute's trials going fine

However, speaking to TNIE, B Suresh, Pro Chancellor of JSS AHER, said that so far, none among their 32 volunteers have reported any adverse reactions and all are doing fine.

published on : 10th September 2020

India will continue Oxford vaccine trial, says Serum Institute after illness in volunteer pauses trial abroad

Serum Institute of India, under whose aegis the vaccine is to be being tried on 1,600 participants across 17 centres, said that trials in India will continue, irrespective of the latest development.

published on : 9th September 2020

AstraZeneca pauses Oxford COVID-19 vaccine trial after volunteer's unexplained illness

AstraZeneca is one of nine companies currently in late-stage Phase 3 trials for their vaccine candidates. In the US, the company began enrolling 30,000 volunteers across dozens of sites on August 31.

published on : 9th September 2020

UNICEF to lead global procurement, supply of COVID vaccines; Australia to fund two potential candidates

UNICEF is the world's largest single vaccine buyer, procuring more than 2 billion doses of various vaccines annually for routine immunisation and outbreak response on behalf of nearly 100 countries.

published on : 7th September 2020

AstraZeneca's COVID-19 vaccine reaches phase 3 clinical trials in US, says Donald Trump

The UK-based global biopharmaceutical company AstraZeneca is leading the trial as regulatory sponsor.

published on : 1st September 2020

Phase two trials of Oxford's COVID vaccine start in Mysuru hospital

The ICMR will collect 100 samples from across the country for further study and look into modifications.

published on : 30th August 2020

If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

published on : 24th August 2020

Australia to manufacture 'promising' COVID-19 vaccine, free distribution for citizens

Prime Minister Scott Morrison said that Australia had reached a deal with Swedish-British pharmaceutical company AstraZeneca to receive the COVID-19 vaccine it is developing with Oxford University.

published on : 18th August 2020

Mexico to produce Oxford COVID-19 vaccine pending results, approval

Production of the vaccine in Mexico and Argentina would allow for distribution throughout Latin America, except for Brazil, which had already reached its own agreement with the drug maker.

published on : 14th August 2020

Hotspots Mumbai, Pune to help test Oxford COVID-19 vaccine efficacy: Serum Institute of India

By end of August, between 4,000 to 5,000 people in Pune and Mumbai will be injected with the vaccine as part of trials that are scheduled to last over two months, SII said.

published on : 23rd July 2020

COVID-19 vaccine to cost Rs 1,000 per dose, says Serum Institute CEO

Adra Poonawalla told TNIE that the mass production of vaccine against the COVID-19 will start in the first quarter of next year while the human trials in India will start next month.

published on : 22nd July 2020
1 2 > 
IPL_2020